$DRIO
DarioHealth Corp. Stock $drio

$drio Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000114420418058882 Filed on November 13, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$1.700M	$1.879M	$1.375M
YoY Change	7.59%	36.65%	88.87%
Cost Of Revenue	$1.480M	$1.411M	$1.099M
YoY Change	46.53%	28.39%	68.56%
Gross Profit	$220.0K	$468.0K	$276.0K
YoY Change	-61.4%	69.57%	263.16%
Gross Profit Margin	12.94%	24.91%	20.07%
Selling, General & Admin	$4.450M	$3.530M	$2.460M
YoY Change	56.69%	43.5%	14.95%
% of Gross Profit	2022.73%	754.27%	891.3%
Research & Development	$930.0K	$997.0K	$797.0K
YoY Change	9.41%	25.09%	20.94%
% of Gross Profit	422.73%	213.03%	288.77%
Depreciation & Amortization	$50.00K	$60.00K	$60.00K
YoY Change	25.0%	0.0%	-25.0%
% of Gross Profit	22.73%	12.82%	21.74%
Operating Expenses	$5.380M	$4.399M	$3.255M
YoY Change	45.8%	35.15%	16.37%
Operating Profit	-$5.160M	-$3.931M	-$2.979M
YoY Change	65.38%	31.96%	9.48%
Interest Expense	$170.0K	-$10.00K	$10.00K
YoY Change	-101.93%	-200.0%	-99.53%
% of Operating Profit
Other Income/Expense, Net		-$132.0K	$6.000K
YoY Change		-2300.0%	-99.72%
Pretax Income	-$4.980M	-$4.060M	-$2.980M
YoY Change	-58.22%	36.24%	388.52%
Income Tax
% Of Pretax Income
Net Earnings	-$4.980M	-$4.063M	-$2.973M
YoY Change	-58.22%	36.66%	386.58%
Net Earnings / Revenue	-292.94%	-216.23%	-216.22%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.895M	-$3.441M	-$5.960M
COMMON SHARES
Basic Shares Outstanding	25.94M shares	21.34M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.20M	$11.60M	$6.500M
YoY Change	180.0%	78.46%	80.56%
Cash & Equivalents	$11.00M	$11.43M	$6.262M
Short-Term Investments	$200.0K	$200.0K	$200.0K
Other Short-Term Assets	$66.00K
YoY Change	-56.86%
Inventory	$1.377M	$1.020M	$900.0K
Prepaid Expenses
Receivables	$200.0K	$400.0K	$400.0K
Other Receivables	$600.0K	$500.0K	$800.0K
Total Short-Term Assets	$13.31M	$13.53M	$8.600M
YoY Change	120.2%	57.3%	53.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$733.0K	$758.0K	$800.0K
YoY Change	-15.65%	-5.25%	-27.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$0.00
YoY Change
Total Long-Term Assets	$776.0K	$805.0K	$900.0K
YoY Change	-14.82%	-10.56%	-18.18%
TOTAL ASSETS
Total Short-Term Assets	$13.31M	$13.53M	$8.600M
Total Long-Term Assets	$776.0K	$805.0K	$900.0K
Total Assets	$14.09M	$14.33M	$9.500M
YoY Change	102.52%	50.87%	41.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.600M	$2.200M	$2.000M
YoY Change	36.84%	10.0%	100.0%
Accrued Expenses	$880.0K
YoY Change	105.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.164M	$3.922M	$3.300M
YoY Change	71.28%	18.85%	65.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.164M	$3.922M	$3.300M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$5.200M	$3.900M	$3.300M
YoY Change	73.33%	18.18%	43.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$89.25M	-$84.27M
YoY Change	25.78%
Common Stock	$8.000K	$7.000K
YoY Change	14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.925M	$10.41M	$6.100M
YoY Change
Total Liabilities & Shareholders Equity	$14.09M	$14.33M	$9.500M
YoY Change	102.52%	50.87%	41.79%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$4.980M	-$4.063M	-$2.973M
YoY Change	-58.22%	36.66%	386.58%
Depreciation, Depletion And Amortization	$50.00K	$60.00K	$60.00K
YoY Change	25.0%	0.0%	-25.0%
Cash From Operating Activities	-$3.440M	-$3.240M	-$2.390M
YoY Change	43.33%	35.56%	-12.13%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00K	-$30.00K	-$30.00K
YoY Change	-85.71%	0.0%	-81.25%
Acquisitions
YoY Change
Other Investing Activities	$10.00K	-$10.00K	$0.00
YoY Change	-200.0%		-100.0%
Cash From Investing Activities	-$10.00K	-$30.00K	-$40.00K
YoY Change	-92.86%	-25.0%	-87.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.020M	9.690M	4.800M
YoY Change	-30300.0%	101.88%
NET CHANGE
Cash From Operating Activities	-3.440M	-3.240M	-2.390M
Cash From Investing Activities	-10.00K	-30.00K	-40.00K
Cash From Financing Activities	3.020M	9.690M	4.800M
Net Change In Cash	-430.0K	6.420M	2.370M
YoY Change	-83.14%	170.89%	-178.22%
FREE CASH FLOW
Cash From Operating Activities	-$3.440M	-$3.240M	-$2.390M
Capital Expenditures	-$20.00K	-$30.00K	-$30.00K
Free Cash Flow	-$3.420M	-$3.210M	-$2.360M
YoY Change	51.33%	36.02%	-7.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11427000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3718000	USD
CY2018Q3	us-gaap	Short Term Investments ShortTermInvestments	184000	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	258000	USD
CY2018Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	374000	USD
CY2017Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	282000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	523000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	604000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	13528000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	6046000	USD
CY2018Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	47000	USD
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	42000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	758000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	869000	USD
CY2018Q3	us-gaap	Assets Assets	14333000	USD
CY2017Q4	us-gaap	Assets Assets	6957000	USD
CY2018Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2203000	USD
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1852000	USD
CY2018Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1334000	USD
CY2017Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1163000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3922000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3015000	USD
CY2017Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1000	USD
CY2018Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	7000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	7000	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	94675000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	74892000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84271000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70958000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	10411000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	3941000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14333000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6957000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1411000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1099000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4152000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2850000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	468000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	276000	USD
	us-gaap	Gross Profit GrossProfit	1542000	USD
	us-gaap	Gross Profit GrossProfit	742000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	997000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	797000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2749000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2450000	USD
CY2018Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2693000	USD
CY2017Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1677000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6820000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	5707000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	709000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	781000	USD
CY2018Q3	us-gaap	Revenues Revenues	1879000	USD
CY2017Q3	us-gaap	Revenues Revenues	1375000	USD
	us-gaap	Revenues Revenues	5694000	USD
	us-gaap	Revenues Revenues	3592000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4506000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3887000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	4399000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	3255000	USD
	us-gaap	Operating Expenses OperatingExpenses	14075000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6332000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2262269	shares
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	707000	USD
	us-gaap	Operating Expenses OperatingExpenses	12044000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3931000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2979000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12533000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11302000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-132000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-288000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-132000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-287000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1176000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-4063000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-2973000	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4063000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2973000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13313000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12478000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.67
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.40
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23533328	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9950443	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19733291	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8931460	shares
CY2018Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	406000	USD
CY2017Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	323000	USD
CY2018Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	614000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	861000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	1020000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	1184000	USD
CY2017	us-gaap	Inventory Write Down InventoryWriteDown	190000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-6541000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9470000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	809000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1514000	USD
CY2017	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	874000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	431000	USD
CY2017	drio	Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability To Equity AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity	8655000	USD
CY2017	drio	Preferred Stock Issued During Period Value New Issue PreferredStockIssuedDuringPeriodValueNewIssue	3711000	USD
CY2017	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2017	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	0	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1294000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	663000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-15743000	USD
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	726000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y0M14D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3284000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3062000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15720000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13469000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7709000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5169000	USD
CY2018Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1020357	shares
CY2018Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	385000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	USD
CY2018Q3	drio	Deemed Dividend Related To Warrant Exchange Agreement DeemedDividendRelatedToWarrantExchangeAgreement	0	USD
CY2017Q3	drio	Deemed Dividend Related To Warrant Exchange Agreement DeemedDividendRelatedToWarrantExchangeAgreement	0	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1093000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6262000	USD
	drio	Payment For Directors And Employees Under Shares For Cash Program PaymentForDirectorsAndEmployeesUnderSharesForCashProgram	286000	USD
	drio	Payment For Directors And Employees Under Shares For Cash Program PaymentForDirectorsAndEmployeesUnderSharesForCashProgram	183000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	385000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2018Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	809000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6034000	USD
	drio	Deemed Dividend Related To Warrant Value Exchange Agreement DeemedDividendRelatedToWarrantValueExchangeAgreement	0	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1786000	USD
	drio	Deemed Dividend Related To Warrant Exchange Agreement DeemedDividendRelatedToWarrantExchangeAgreement	493000	USD
	drio	Deemed Dividend Related To Warrant Exchange Agreement DeemedDividendRelatedToWarrantExchangeAgreement	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12820000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12478000	USD
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3284000	USD
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3062000	USD
	us-gaap	Depreciation Depreciation	160000	USD
	us-gaap	Depreciation Depreciation	155000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	92000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	193000	USD
	drio	Increase Decrease In Other Receivables And Prepaid Expense IncreaseDecreaseInOtherReceivablesAndPrepaidExpense	-81000	USD
	drio	Increase Decrease In Other Receivables And Prepaid Expense IncreaseDecreaseInOtherReceivablesAndPrepaidExpense	264000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	457000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	191000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8031000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8223000	USD
	drio	Payments For Proceeds From Acquire Leases Held For Investment PaymentsForProceedsFromAcquireLeasesHeldForInvestment	5000	USD
	drio	Payments For Proceeds From Acquire Leases Held For Investment PaymentsForProceedsFromAcquireLeasesHeldForInvestment	-3000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	20000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-77000	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	15720000	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	13469000	USD
CY2018Q2	drio	Class Of Warrant Or Right Aggregate With Shares Consideration ClassOfWarrantOrRightAggregateWithSharesConsideration	636752	shares
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	49000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-287000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1176000	USD
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25691724	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14074238	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25691724	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14074238	shares
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1890257	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1890257	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
	drio	Reclassifiacation Of Warrants From Liability To Equity ReclassifiacationOfWarrantsFromLiabilityToEquity	0	USD
	drio	Reclassifiacation Of Warrants From Liability To Equity ReclassifiacationOfWarrantsFromLiabilityToEquity	8655000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1169000	USD
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	0	USD
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	0	USD
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="font-size: 10pt;"><div style="font-size:10pt;;display:inline;"><div style="font-family:times new roman,times,serif;;display:inline;"><div style="font-weight:bold;display:inline;width:100%;">NOTE 3: - UNAUDITED INTERIM FINANCIAL STATEMENTS</div></div></div></div><div style="clear:both;"></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: "times new roman", serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 0px; text-align: justify; background: none;"><div style="font-family: "times new roman", serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited interim consolidated financial statements as of September 30, 2018, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company's consolidated financial position as of September 30, 2018, and the Company's consolidated results of operations and the Company's consolidated cash flows for the nine months ended September 30, 2018. Results for the nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Inventory Write Down InventoryWriteDown	33000	USD
	drio	Bank And Credit Card Charges And Commissions BankAndCreditCardChargesAndCommissions	239000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1000	USD
CY2018Q2	drio	Deemed Dividend Related To Warrant Exchange Agreement DeemedDividendRelatedToWarrantExchangeAgreement	493000	USD
CY2018Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7561028	shares
CY2018Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.90
	drio	Bank And Credit Card Charges And Commissions BankAndCreditCardChargesAndCommissions	9000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		USD
CY2017	drio	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised		USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2017Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	184969	shares
CY2018Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	296
CY2018Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	164567	shares
	drio	Preferred Stock Issued During Period Value New Issue PreferredStockIssuedDuringPeriodValueNewIssue	9269000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-74000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	16000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-164000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	36000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	351000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	171000	USD
CY2018Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	DarioHealth Corp.
	dei	Entity Central Index Key EntityCentralIndexKey	0001533998
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Trading Symbol TradingSymbol	DRIO
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25936165	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Small Business EntitySmallBusiness	true

Files In Submission

Name	View Source	Status
0001144204-18-058882-index-headers.html	Edgar Link	pending
0001144204-18-058882-index.html	Edgar Link	pending
0001144204-18-058882.txt	Edgar Link	pending
0001144204-18-058882-xbrl.zip	Edgar Link	pending
drio-20180930.xml	Edgar Link	completed
drio-20180930.xsd	Edgar Link	pending
drio-20180930_cal.xml	Edgar Link	unprocessable
drio-20180930_def.xml	Edgar Link	unprocessable
drio-20180930_lab.xml	Edgar Link	unprocessable
drio-20180930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv506117_10q.htm	Edgar Link	pending
tv506117_ex31-1.htm	Edgar Link	pending
tv506117_ex31-2.htm	Edgar Link	pending
tv506117_ex32-1.htm	Edgar Link	pending
tv506117_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DRIO
DarioHealth Corp. Stock $drio

2018 Q4 Form 10-Q Financial Statement

#000114420418058882 Filed on November 13, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO DarioHealth Corp. Stock $drio

2018 Q4 Form 10-Q Financial Statement

#000114420418058882 Filed on November 13, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO
DarioHealth Corp. Stock $drio